<clinical_study>
  <!-- This xml conforms to an XML Schema at:
    https://clinicaltrials.gov/ct2/html/images/info/public.xsd -->
  <required_header>
    <download_date>ClinicalTrials.gov processed this data on May 29, 2018</download_date>
    <link_text>Link to the current ClinicalTrials.gov record.</link_text>
    <url>https://clinicaltrials.gov/show/NCT00805181</url>
  </required_header>
  <id_info>
    <org_study_id>CER08-170</org_study_id>
    <secondary_id>PRD-08-I-4</secondary_id>
    <nct_id>NCT00805181</nct_id>
  </id_info>
  <brief_title>Kinetics of Biomarkers in Acute Pyelonephritis</brief_title>
  <official_title>Kinetics of Procalcitonin, C-reactive Protein and Pyuria in Uncomplicated Pyelonephritis in Women: A Pilot Study</official_title>
  <sponsors>
    <lead_sponsor>
      <agency>University Hospital, Geneva</agency>
      <agency_class>Other</agency_class>
    </lead_sponsor>
  </sponsors>
  <source>University Hospital, Geneva</source>
  <oversight_info>
    <has_dmc>No</has_dmc>
  </oversight_info>
  <brief_summary>
    <textblock>
      The objective of this study is to explore the kinetics of biomarkers in 30 adult female
      patients with uncomplicated acute pyelonephritis.
    </textblock>
  </brief_summary>
  <detailed_description>
    <textblock>
      We will measure c-reactive protein, procalcitonin, pyuria and a new blood biomarker
      (Signature TM) everyday till normalization of these markers in 30 adult female patients with
      uncomplicated acute pyelonephritis.
    </textblock>
  </detailed_description>
  <overall_status>Completed</overall_status>
  <start_date>December 2008</start_date>
  <completion_date type="Actual">April 2010</completion_date>
  <primary_completion_date type="Actual">April 2010</primary_completion_date>
  <study_type>Observational</study_type>
  <has_expanded_access>No</has_expanded_access>
  <study_design_info>
    <observational_model>Cohort</observational_model>
    <time_perspective>Prospective</time_perspective>
  </study_design_info>
  <primary_outcome>
    <measure>Blood and urine biomarkers (procalcitonin, C-reactive protein, SIGNATURE(TM) test, pyuria</measure>
    <time_frame>Daily till day 15.</time_frame>
  </primary_outcome>
  <number_of_groups>1</number_of_groups>
  <enrollment type="Anticipated">30</enrollment>
  <condition>Pyelonephritis</condition>
  <arm_group>
    <arm_group_label>Acute uncomplicated pyelonephritis</arm_group_label>
  </arm_group>
  <eligibility>
    <study_pop>
      <textblock>
        30 adult females with acute uncomplicated pyelonephritis
      </textblock>
    </study_pop>
    <sampling_method>Non-Probability Sample</sampling_method>
    <criteria>
      <textblock>
        Inclusion Criteria:

          -  &gt; 18 years

          -  Flank/loin pain or tenderness, or both and fever &gt; 38Â°C during the last 48 hours and
             pyuria

        Exclusion Criteria:

          -  Pregnancy

          -  Presence of indwelling catheters

          -  Known polycystic kidney disease or any malformation of the urinary tract, or single
             kidney; renal transplant recipients; acute or chronic renal failure requiring dialysis

          -  Recent discharge from hospital (during the last 10 days); ongoing antibiotic treatment

          -  Known severe immunosuppression: Receiver of solid-organ or hematopoietic stem cells
             transplants; neutropenia ( &lt; 1 G neutrophils / L); chronic (more than 14 days) use of
             systemic glucocorticoids (&gt;10 mg/d of prednisone); active use of immunosuppressive
             therapy for the treatment of auto-immune or inflammatory disease; HIV infection with &lt;
             350 CD4+ cells / ml or unknown CD4+ status

          -  Pyelonephritis initially identified as complicated: obstruction of urinary tract,
             urinary stone; history of renal infection in the last 15 days

          -  Patient with severe sepsis or septic shock
      </textblock>
    </criteria>
    <gender>Female</gender>
    <minimum_age>18 Years</minimum_age>
    <maximum_age>N/A</maximum_age>
    <healthy_volunteers>No</healthy_volunteers>
  </eligibility>
  <overall_official>
    <last_name>Olivier T Rutschmann, MD, MPH</last_name>
    <role>Principal Investigator</role>
    <affiliation>University Hospital, Geneva</affiliation>
  </overall_official>
  <location>
    <facility>
      <name>Geneva University Hospitals</name>
      <address>
        <city>Geneva</city>
        <zip>1211</zip>
        <country>Switzerland</country>
      </address>
    </facility>
  </location>
  <location_countries>
    <country>Switzerland</country>
  </location_countries>
  <verification_date>June 2010</verification_date>
  <!-- For several months we've had both old and new date name tags                             -->
  <!-- Now, the old date names have been dropped.                                               -->
  <!-- The new date name replacements are:                                                      -->
  <!--     OLD (gone)                                        NEW (in use)                       -->
  <!--   lastchanged_date                         becomes   last_update_submitted               -->
  <!--   firstreceived_date                       becomes   study_first_submitted               -->
  <!--   firstreceived_results_date               becomes   results_first_submitted             -->
  <!--   firstreceived_results_disposition_date   becomes   disposition_first_submitted         -->
  <study_first_submitted>December 8, 2008</study_first_submitted>
  <study_first_submitted_qc>December 8, 2008</study_first_submitted_qc>
  <study_first_posted type="Estimate">December 9, 2008</study_first_posted>
  <last_update_submitted>October 6, 2010</last_update_submitted>
  <last_update_submitted_qc>October 6, 2010</last_update_submitted_qc>
  <last_update_posted type="Estimate">October 7, 2010</last_update_posted>
  <responsible_party>
    <name_title>Medical Director</name_title>
    <organization>University Hospital, Geneva</organization>
  </responsible_party>
  <condition_browse>
    <!-- CAUTION:  The following MeSH terms are assigned with an imperfect algorithm            -->
    <mesh_term>Pyelonephritis</mesh_term>
  </condition_browse>
  <!-- Results have not yet been posted for this study                                          -->
</clinical_study>

